Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer. - Scott JS; Evans L; Astles PC; Argyrou A; Bagal SK; Beattie D; Braybrooke EL; Cassar DJ; Crafter C; Diène C; Fairley G; Fallan C; et al. (Journal of medicinal chemistry, 2026)